|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-2.37/-1.91
|
企業價值
486.16M
|
資產負債 |
每股賬面淨值
3.75
|
現金流量 |
現金流量率
--
|
損益表 |
收益
20.76M
|
每股收益
0.30
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2024/05/16 19:41 EDT
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders. |